PD-1/PD-L1 blockade indirectly offers improved NK cell survival and function by preventing the expansion and persistence of inhibitory Tregs in the tumor microenvironment (63) and potentially by mitigating CD4+ T helper cell exhaustion. The gene discussed is CD4; the disease is neoplasm.